Skip to main content
. 2012 Aug 6;7(8):e41720. doi: 10.1371/journal.pone.0041720

Figure 1. Predicted age-specific efficacy on severe RV-GE and all RV-GE.

Figure 1

A) Vaccine efficacy: Severe RV-GE. B) Vaccine efficacy: All RV-GE.